A
Andrea Abati
Researcher at National Institutes of Health
Publications - 60
Citations - 6060
Andrea Abati is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Melanoma & Antigen. The author has an hindex of 32, co-authored 60 publications receiving 5787 citations.
Papers
More filters
Journal ArticleDOI
Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma
Mark E. Dudley,John R. Wunderlich,James Chih-Hsin Yang,Richard M. Sherry,Suzanne L. Topalian,Nicholas P. Restifo,Richard E. Royal,Udai S. Kammula,Donald E. White,Sharon Mavroukakis,Linda J. Rogers,Gerald J. Gracia,Stephanie Jones,David P. Mangiameli,Michelle M. Pelletier,Juan Gea-Banacloche,Michael R. Robinson,David Berman,Armando C. Filie,Andrea Abati,Steven A. Rosenberg +20 more
TL;DR: Lymphodepleting chemotherapy followed by the transfer of highly avid antitumor lymphocytes can mediate significant tumor regression in heavily pretreated patients with IL-2 refractory metastatic melanoma.
Journal ArticleDOI
The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2)
Thomas Litman,Mariafiorella Brangi,Eric Hudson,Patricia Fetsch,Andrea Abati,Douglas D. Ross,Keisuke Miyake,James H. Resau,Susan E. Bates +8 more
TL;DR: The studies suggest that the ABC half-transporter, MXR, is a potent, new mechanism for conferring multiple drug resistance and its role in clinical oncology is required.
Journal ArticleDOI
The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation
Zubair W. Baloch,Edmund S. Cibas,Douglas P. Clark,Lester J. Layfield,Britt-Marie Ljung,Martha B. Pitman,Andrea Abati +6 more
TL;DR: The two-day "live" conference in October, attended by 154 registrants, gave the committees an in-depth opportunity to present their conclusions and debate controversial areas, and the establishment of an on-line educational cytopathology atlas.
Journal ArticleDOI
High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology.
Upendra P. Hegde,Armando C. Filie,Richard F. Little,John E. Janik,Nicole Grant,Seth M. Steinberg,Kieron Dunleavy,Elaine S. Jaffe,Andrea Abati,Maryalice Stetler-Stevenson,Wyndham H. Wilson +10 more
TL;DR: It is hypothesize that the biologic phenotype associated with colonization of extranodal sites leads to CNS spread, possibly related to the microenvironment.
Journal ArticleDOI
Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer.
Armando E. Giuliano,Debra Hawes,Karla V. Ballman,Pat Whitworth,Peter W. Blumencranz,Douglas S. Reintgen,Monica Morrow,A. Marilyn Leitch,Kelly K. Hunt,Linda M. McCall,Andrea Abati,Richard J. Cote +11 more
TL;DR: Among women receiving breast-conserving therapy and SLN dissection, immunohistochemical evidence of SLN metastasis was not associated with overall survival over a median of 6.3 years, whereas occult bone marrow metastasis, although rare, was associated with decreased survival.